About this item:

49 Views | 21 Downloads

Author Notes:

Macy L. Early, Division of Hematology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21231, USA. Email: mearly4@jhmi.edu

We thank our patients, who patiently partner with us as we learn to provide them with best care we can. We also thank our funders. Macy L. Early is supported by the American Society of Haematology Medical Student Physician‐Scientist Career Development Award. Elizabeth Linton is supported by a T32 from the National Institute on Aging, National Institutes of Health. Lydia H. Pecker is funded by NHLBI/NIH K23HL146841, the American Society of Haematology, and the Mellon Foundation. Eboni I. Lance is supported by a K23 from the National Heart, Lung, and Blood Institute. Macy L. Early and Elizabeth Linton designed the research question, with guidance from Sophie Lanzkron and Lydia H. Pecker, and performed statistical analysis. Macy L. Early collected data and wrote the manuscript. Allison Bosch, Timothy Campbell and Felicia Hill‐Brigg recruited patients, performed cognitive testing and collected demographic information on participants. All authors provided feedback on the manuscript, and Lydia H. Pecker, Eboni I. Lance and Sophie Lanzkron provided extensive comments and revision, in addition to continuous mentorship.

Sophie Lanzkron receives funding from Global Blood Therapeutics, Imara, Shire, Novartis, and the NIH; is a consultant for Bluebird Bio and Novo Nordisk; and holds stock in Pfizer and Teva. The other authors have nothing to disclose.

Subject:

Keywords:

  • cognitive performance
  • cognitive screening
  • health literacy
  • Montreal Cognitive Assessment
  • sickle cell disease

The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains

Tools:

Journal Title:

BRITISH JOURNAL OF HAEMATOLOGY

Volume:

Volume 198, Number 2

Publisher:

, Pages 382-390

Type of Work:

Article | Final Publisher PDF

Abstract:

Adults with sickle cell disease (SCD) are at risk for cognitive impairment, which causes significant morbidity. Guidelines support routine cognitive screening, but no screening test is validated in this population. We explored the Montreal Cognitive Assessment (MoCA) as a possible screening test in SCD. We administered the MoCA; a literacy test, the Wide Range Achievement Test, fourth edition (WRAT‐4); and a health literacy test, the Shortened Test of Functional Health Literacy in Adults (S‐TOFHLA) to adults with SCD and gathered clinical variables through chart review. Spearman's rho, Mann–Whitney, and Kruskal–Wallis tests and quantile regression models were used. Among our sample of 49 adults with SCD, the median MoCA score was 25.0 [interquartile range (IQR) 22.0–28.0]. Higher educational attainment was associated with MoCA scores (p = 0.001). In multivariable models, MoCA scores were associated with S‐TOFHLA (p = 0.001) and WRAT‐4 Reading (p = 0.002) scores, and overt stroke (p = 0.03) at the median. This pilot study adds to the limited literature of cognitive screening tests in adults with SCD and demonstrates a relationship between MoCA scores and measures of literacy and health literacy. The MoCA is a promising option for briefly screening for cognitive impairment in adults with SCD, though further study is needed to confirm its validity.

Copyright information:

© 2022 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Export to EndNote